Log in
Enquire now
‌

US Patent 11883410 Preventative and therapeutic agents for sarcopenia

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118834100
Patent Inventor Names
Daisuke Kajiwara0
Masaki Inada0
Date of Patent
January 30, 2024
0
Patent Application Number
170474360
Date Filed
April 18, 2019
0
Patent Citations
‌
US Patent 9062035 Piperazine compound capable of inhibiting prostaglandin D synthase
0
‌
US Patent 8765750 Piperazine compound having a PGDS inhibitory effect
0
‌
US Patent 8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
0
‌
US Patent 7238718 Method for treating myolytic disease and method for screening antimyolytic agent
0
‌
US Patent 7951956 Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
0
Patent Primary Examiner
‌
Theodore R. Howell
0
CPC Code
‌
A61P 21/00
0
‌
A61K 31/4184
0
‌
A61K 31/5377
0
‌
A61P 21/06
0
‌
A61K 31/454
0
Patent abstract

This invention relates to a preventive and/or therapeutic agent for sarcopenia, comprising a prostaglandin D2 production inhibitor as an active ingredient.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11883410 Preventative and therapeutic agents for sarcopenia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.